CCM
RDY icon

Coldstream Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Coldstream Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,257
Closed -$56.1K – 2828
2025
Q1 		$56.1K Buy
+4,257
New +$58.7K ﹤0.01% 1649

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Coldstream Capital Management's RDY Position: Q2 2025 in Review

Coldstream Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 4,257 shares — an estimated $56.1K sold.

Coldstream Capital Management first reported a position in RDY in Q1 2025 and held it in 1 quarter. The position peaked at $56.1K in Q1 2025. 242 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Coldstream Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 4,257 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $56.1K.
  • Coldstream Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Dr. Reddy's Laboratories position peaked at $56.1K in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.